These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. NIH scientists find cofactor for HIV entry. National Institutes of Health. James JS AIDS Treat News; 1996 May; (no 247):1, 6. PubMed ID: 11363488 [TBL] [Abstract][Full Text] [Related]
3. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications]. Azevedo-Pereira JM; Santos-Costa Q Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693 [TBL] [Abstract][Full Text] [Related]
4. Elusive HIV co-factor identified. AIDS Alert; 1996 Jul; 11(7):83. PubMed ID: 11363554 [TBL] [Abstract][Full Text] [Related]
5. [7TM receptors--from the olfactory system and new hormones against HIV infection]. Schwartz TW Ugeskr Laeger; 1997 Feb; 159(9):1239-45. PubMed ID: 9072867 [TBL] [Abstract][Full Text] [Related]
6. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion. Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R Virol J; 2006 Dec; 3():104. PubMed ID: 17187670 [TBL] [Abstract][Full Text] [Related]
7. CKR-5--understanding the news. James JS AIDS Treat News; 1996 Sep; (No 254):6-7. PubMed ID: 11363820 [TBL] [Abstract][Full Text] [Related]
8. Pouncing on the chemokine receptor Chimera. Mascolini M J Int Assoc Physicians AIDS Care; 1997 Aug; 3(8):13-24. PubMed ID: 11364629 [TBL] [Abstract][Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
10. 2-deoxy-D-glucose as a potential drug against fusogenic viruses including HIV. Parris GE Med Hypotheses; 2008; 70(4):776-82. PubMed ID: 17920779 [TBL] [Abstract][Full Text] [Related]
11. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
12. Be kind to your chemokines. Gilden D GMHC Treat Issues; 1996; 10(6/7):28. PubMed ID: 11363642 [TBL] [Abstract][Full Text] [Related]
13. HIV-1 Env-chemokine receptor interactions in primary human macrophages: entry and beyond. Collman RG Res Initiat Treat Action; 2003; 8(2):6-9. PubMed ID: 12845769 [TBL] [Abstract][Full Text] [Related]
14. Antiviral properties of two trimeric recombinant gp41 proteins. Delcroix-GenĂȘte D; Quan PL; Roger MG; Hazan U; Nisole S; Rousseau C Retrovirology; 2006 Mar; 3():16. PubMed ID: 16515685 [TBL] [Abstract][Full Text] [Related]
15. HIV chemokine receptor inhibitors as novel anti-HIV drugs. Princen K; Schols D Cytokine Growth Factor Rev; 2005 Dec; 16(6):659-77. PubMed ID: 16005254 [TBL] [Abstract][Full Text] [Related]
16. Inhibitors of the entry of HIV into host cells. Meanwell NA; Kadow JF Curr Opin Drug Discov Devel; 2003 Jul; 6(4):451-61. PubMed ID: 12951808 [TBL] [Abstract][Full Text] [Related]
17. Novel, rapid assay for measuring entry of diverse enveloped viruses, including HIV and rabies. Saeed MF; Kolokoltsov AA; Davey RA J Virol Methods; 2006 Aug; 135(2):143-50. PubMed ID: 16584792 [TBL] [Abstract][Full Text] [Related]
18. [CCR5, a new target of anti-HIV drugs]. Han YX; Jiang JD Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):635-9. PubMed ID: 14650176 [TBL] [Abstract][Full Text] [Related]
19. Unwelcome guests with master keys: how HIV enters cells and how it can be stopped. Doms RW Top HIV Med; 2004; 12(4):100-3. PubMed ID: 15516706 [TBL] [Abstract][Full Text] [Related]
20. [Chemokine receptors: their role in human immunodeficiency virus (HIV) pathogenicity and resistance to HIV infections]. Us D Mikrobiyol Bul; 2003 Jan; 37(1):75-87. PubMed ID: 12838682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]